- Home
- ALDX vs DFDV Comparison
ALDX vs DFDV Comparison
Compare ALDX & DFDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- DFDV
- Stock Information
- Founded
- ALDX 2004
- DFDV 2018
- Country
- ALDX United States
- DFDV United States
- Employees
- ALDX N/A
- DFDV N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- DFDV Finance: Consumer Services
- Sector
- ALDX Health Care
- DFDV Finance
- Exchange
- ALDX Nasdaq
- DFDV Nasdaq
- Market Cap
- ALDX 326.6M
- DFDV 340.7M
- IPO Year
- ALDX 2014
- DFDV N/A
- Fundamental
- Price
- ALDX $5.81
- DFDV $20.21
- Analyst Decision
- ALDX Strong Buy
- DFDV Buy
- Analyst Count
- ALDX 2
- DFDV 1
- Target Price
- ALDX $9.50
- DFDV $45.00
- AVG Volume (30 Days)
- ALDX 917.6K
- DFDV 3.1M
- Earning Date
- ALDX 08-07-2025
- DFDV 08-12-2025
- Dividend Yield
- ALDX N/A
- DFDV N/A
- EPS Growth
- ALDX N/A
- DFDV N/A
- EPS
- ALDX N/A
- DFDV 1.17
- Revenue
- ALDX N/A
- DFDV $3,520,660.00
- Revenue This Year
- ALDX N/A
- DFDV $70.03
- Revenue Next Year
- ALDX $29.89
- DFDV $142.86
- P/E Ratio
- ALDX N/A
- DFDV $17.26
- Revenue Growth
- ALDX N/A
- DFDV 97.13
- 52 Week Low
- ALDX $1.14
- DFDV $0.49
- 52 Week High
- ALDX $7.20
- DFDV $53.88
- Technical
- Relative Strength Index (RSI)
- ALDX 71.16
- DFDV 54.66
- Support Level
- ALDX $5.34
- DFDV $15.00
- Resistance Level
- ALDX $5.73
- DFDV $21.80
- Average True Range (ATR)
- ALDX 0.27
- DFDV 2.45
- MACD
- ALDX 0.01
- DFDV 0.51
- Stochastic Oscillator
- ALDX 77.36
- DFDV 82.25
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About DFDV DeFi Development Corp. Common Stock
DeFi Development Corp is an AI-powered online platform that connects the commercial real estate industry by providing data and software subscriptions as well as value-add services to multifamily and commercial property professionals.